Cellular immune responses in neonates

International Reviews of Immunology

Volumn 19, Issue 2-3, 2000, Pages 173-193

  Fadel, S ^a   Sarzotti, M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cytokines; Cytotoxicity; DNA vaccines; Fetus; Newborn; T lymphocytes

Indexed keywords

EID: 0034057886     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830180009088504     Document Type: Article

References (123)

1. A.M. Silverstein, A History of Immunology. 1989, San Diego: Academic Press, Inc. p. 422.
2. R.E. Billingham, L. Brent and P.B. Medawar, Actively acquired tolerance of foreign cells. Nature, 1953, 172: 603-6.
3. A.B. Kenny and W.H. Hitzig, Bone marrow transplantation for severe combined immunodeficiency disease. Reported from 1968 to 1977, Eur. J. Pediatr., 1979, 131 (3): 155-77.
4. R.H. Buckley et al., Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J. Immunol., 1986, 136(7): 2398-407.
5. S.A. Plotkin and E.A. Mortimer (Eds.) Vaccines. Second edn. 1994, W.B. Saunders Company: Philadelphia, p. 996.
6. J.P. Ridge, E.J. Fuchs and P. Matzinger, Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science, 1996, 271(5256): 1723-6.
7. M. Sarzotti, D.S. Robbins and P.M. Hoffman, Induction of protective CTL responses in newborn mice by a murine retrovirus. Science, 1996, 271(5256): 1726-8.
8. D.H. Schwartz et al., Priming of virus-immune memory T cells in newborn mice. Infect. Immun., 1984, 43(1): 202-5.
9. J.B. Solomon, Foetal and neonatal immunology. Frontiers of Biology, A. Neuberger and E.L. Tatum (Eds.) Vol. 20. 1971, Amsterdam: North-Holand Publishing Company, p. 381.
10. H.W. Schroeder Jr., G.C. Ippolito and S. Shiokawa, Regulation of the antibody repertoire through control of HCDR3 diversity. Vaccine, 1998, 16(14,15): 1383-90.
11. A.M Silverstein, Ontogeny of the immune response: a perspective. Development of Host Defense, M.D. Cooper (Ed.) 1977, Raven Press; New York. pp. 1-10.
12. R. Ahmed and D. Gray, Immunological memory and protective immunity: understanding their relation. Science, 1996, 272(5258): 54-60.
13. M. Sarzotti, Immunologic tolerance. Curr Opin Hematol, 1997, 4(1): 48-52.
14. I. Miler, The immunity of the human foetus. Developments in Perinatal Medicine. Vol. 3. 1982, The Hague: Martinus Nijhoff Publishers, p 257.
15. M.E. Miller, Host defenses in the human neonate. Monographs in Neonatology, T.K. Oliver (Ed.) 1978, New York: Grune & Stratton. p. 123.
16. J. Butler et al., Humoral immunity in the human neonate. Immunology of the Neonate, G. Burgio, L. Hanson and A. Ugazio (Eds.) 1987, Springer-Verlag: Berlin. pp. 27-36.
17. B.F. Haynes and C.S. Heinly, Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment. J. Exp. Med., 1995, 181(4): 1445-58.
18. D. Campana et al., The expression of T cell receptor-associated proteins during T cell ontogeny in man. J. Immunol., 1989, 142(1): 57-66.
19. C.B. Wilson et al, Ontogeny of T lymphocyte function in the neonate. Am. J. Reprod. Immunol., 1992, 28(3,4): 132-5.
20. M.D. Cooper, The development of cell-mediated and humoral immunity: ontogeny of T and B cells. Host Defense Mechanisms in the Fetus and Newborn. Mead Johnson Symposium on Perinatal and Developmental Medicine. 1972, Ponte Vedra, Florida: Mead Johnson & Company.
21. M.C. Carr, D.P. Stites and H H. Fudenberg, Dissociation of responses to phytohaemagglutinin and adult allogeneic lymphocytes in human foetal lymphoid tissues. Nat. New Biol., 1973, 241(113): 279-81.
22. T. Asantila et al., Xenogeneic reactivity of human fetal lymphocytes. J. Immunol., 1973, 111(3): 984-7.
23. O. Stutman, T-cell development. Immunology of the neonate, G. Burgio, L. Hanson and A.G. Ugazio (Eds.) 1987, Springer-Verlag: Berlin, pp. 5-26.
24. L.A. Husmann et al., Thymocyte subpopulations during early fetal development in the BALB/c mouse. J. Immunol., 1988, 141(3): 736-40.
25. K. Luzuriaga et al., HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J. Immunol., 1995, 154(1): 433-43.
26. R.A. Montgomery and M.J. Dallman, Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J. Immunol., 1991, 147(2): 554-60.
27. P. Lauzurica and M.S. Krangel, Temporal and lineage-specific control of T cell receptor alpha/delta gene rearrangement by T cell receptor alpha and delta enhancers. J. Exp. Med., 1994, 179(6): 1913-21.
28. W. Born et al., Rearrangement of T-cell receptor beta-chain genes during T-cell development. Proc. Natl. Acad. Sci. USA, 1985, 82(9): 2925-9.
29. W. Born et al., Synchronized rearrangement of T-cell gamma and beta, chain genes in fetal thymocyte development. Science, 1986, 234(4775): 479-82.
30. H.R. Snodgrass et al., Ontogeny of the T-cell antigen receptor within the thymus. Nature, 1985, 313(6003): 592-5.
31. D.M. Pardoll et al., Differential expression of two distinct T-cell receptors during thymocyte development. Nature, 1987, 326(6108): 79-81.
32. W.L. Havran and J.P. Allison, Developmentally ordered appearance of thymocytes expressing different T- cell antigen receptors. Nature, 1988, 335(6189): 443-5.
33. M.B. Widmer and E. L. Cooper, Ontogeny of cell-mediated cytotoxicity: induction of CTL in early postnatal thymocytes. J. Immunol., 1979, 122(1): 291-5.
34. B. Adkins and K. Hamilton, Freshly isolated, murine neonatal T cells produce IL-4 in response to anti-CD3 stimulation. J. Immunol., 1992. 149(11): 3448-55.
35. M. Bogue et al., A special repertoire of alpha: beta T cells in0 neonatal mice. EMBO J., 1991, 10(12): 3647-54.
36. A.J. Feeney, Junctional sequences of fetal T cell receptor beta chains have few N regions. J. Exp. Med., 1991, 174(1): 115-24.
37. E. Rothenberg and D. Triglia, Clonal proliferation unlinked to terminal deoxynucleotidyl transferase synthesis in thymocytes of young mice. J. Immunol., 1983, 130(4): 1627-33.
38. B.F. Haynes et al., Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues (published erratum appears in J. Exp. Med., 1989 Feb 1; 169(2): 603). J. Exp. Med., 1988, 168(3). 1061-80.
39. A. Hayward, P. Leibson and A. Arvin, Development of lymphocyte responses to herpes simplex virus following neonatal infection, Immunology of the Neonate, G Burgio, L. Hanson and A. Ugazio (Eds.) 1987, Springer-Verlag: Berlin, pp. 112-19.
40. F. Ciccimarra, Fetal and neonatal immunology. J. Perinat. Med., 1994, 22 (Suppl. 1): 84-7.
41. M.C. Aldhous et al., Age-related ranges of memory, activation, and cytotoxic markers on CD4 and CD8 cells in children. J. Clin. Immunol., 1994, 14(5): 289-98.
42. I. Hannet et al., Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today, 1992, 13(6): 215, 218.
43. R.E. Petty and D.W. Hunt, Neonatal dendritic cells Vaccine, 1998, 16(14,15): 1378-82.
44. C.J. Guidos, I.L. Weissman and B. Adkins, Developmental potential of CD4-8-thymocytes. Peripheral progeny include mature CD4-8- T cells bearing alpha beta T cell receptor. J. Immunol., 1989, 142(11): 3773-80.
45. R, Maccario and G. Burgio, T and NK lymphocyte subpopulation in the neonate, Immunology of the Neonate. G.R. Burgio, L.A. Hanson and A.G. Ugazio (Eds.) 1987, Springer-Verlag: Berlin, pp. 120-129.
46. A. Bonomo, P.J. Kehn and E.M. Shevach, Premature escape of double-positive thymocytes to the periphery of young mice. Possible role in autoimmunity. J. Immunol., 1994, 152(4): 1509-14.
47. P.F. Piguet et al., Post-thymic T lymphocyte maturation during ontogenesis. J. Exp. Med., 1981, 154(3): 581-93.
48. B. Adkins and R.Q. Du, Newborn mice develop balanced Th1/Th2 primary effector responses in vivo but are biased to Th2 secondary responses. J. Immunol., 1998, 160(9): 4217-24.
49. T. Forsthuber, H.C. Yip and P.V. Lehmann, Induction of TH1 and TH2 immunity in neonatal mice. Science, 1996, 271(5256): 1728-30.
50. D.T. Harris et al., Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc. Natl. Acad. Sci. USA, 1992, 89(21): 10006-10.
51. J. Alferink et al., Control of neonatal tolerance to tissue antigens by peripheral T cell trafficking. Science, 1998, 282(5392): 1338-41.
52. A. Townsend and H. Bodmer, Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol., 1989, 7: 601-24.
53. K.A. Smith, Interleukin-2: inception, impact, and implications. Science, 1988, 240(4856): 1169-76.
54. S. Taylor and V.J. Bryson, Impaired production of gamma-interferon by newborn cells in vitro is due to a functionally immature macrophage. J. Immunol., 1985, 134(3): 1493-7.
55. K.R. Schibler et al., Defective production of interleukin-6 by monocytes: a possible mechanism underlying several host defense deficiencies of neonates. Pediatr. Res., 1992, 31(1): 18-21.
56. R.B. Johnston Jr., Function and cell biology of neutrophils and mononuclear phagocytes in the newborn infant. Vaccine, 1998, 16(14,15): 1363-8.
57. R. Klein et al.. Decreased mononuclear and polymorphonuclear chemotaxis in human newborn, infants and young children. Pediatrics, 1977, 60: 467-472.
58. C.B. Wilson, Immunologic basis for increased susceptibility of the neonate to infection. J. Pediatr., 1986, 108(1): 1-12.
59. C.Y. Lu, E.G. Calamai and E.R. Unanue. A defect in the antigen-presenting function of macrophages from neonatal mice. Nature, 1979, 282(5736): 327-9.
60. Y. Suen et al., Dysregulation of lymphokine production in the neonate and its impact on neonatal cell mediated immunity. Vaccine, 1998, 16(14,15): 1369-77.
61. D.J. Nelson and P.G. Holt, Defective regional immunity in the respiratory tract of neonates is attributable to hyporesponsiveness of local dendritic cells to activation signals. J. Immunol., 1995, 155(7): 3517-24.
62. B.A. Chilmonczyk et al., Characterization of the human newborn response to herpesvirus antigen. J. Immunol., 1985, 134(6): 4184-8.
63. A.R Hayward et al., Specific immunity after congenital or neonatal infection with cytomegalovirus or herpes simplex virus. J. Immunol., 1984, 133(5): 2469-73.
64. A. Bot, S. Antohi and C. Bona, Immune response of neonates elicited by somatic transgene vaccination with naked DNA. Front. Biosci , 1997, 2: d173-88.
65. V. Holan, M. Lipoldova and A. Zajicova, Immunological nonreactivity of newborn mice: immaturity of T cells and selective action of neonatal suppressor cells. Cell Immunol., 1991, 137(1): 216-23.
66. T.R. Mosmann and R.L. Coffman, TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol., 1989, 7: 145-73.
67. C. R. Parish, The relationship between humoral and cell-mediated immunity. Transplant. Rev., 1972, 13: 35-66.
68. H.J. Burstein, C.M. Shea and A.K. Abbas, Aqueous antigens induce in vivo tolerance selectively in IL-2- and IFN-gamma-producing (Th1) cells. J. Immunol., 1992, 148(12): 3687-91.
69. P.A. Bretscher et al., Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science, 1992, 257(5069): 539-42.
70. N.A. Hosken et al., The effect of antigen dose on CD4 + T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model J. Exp. Med., 1995, 182(5): 1579-84.
71. C. A. Power, G. Wei and P.A. Bretscher. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. Infect. Immun., 1998, 66(12): 5743-50.
72. J. Kovarik and C.A. Siegrist, Immunity in early life. Immunol. Today, 1998, 19(4): 150-2.
73. C.S. Hsieh et al., T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med., 1995, 181(2): 713-21.
74. Y, Riviere et al., Severity of lymphocytic choriomeningitis virus disease in different strains of suckling mice correlates with increasing amounts of endogenous interferon. J. Exp. Med., 1980, 152(3): 633-40.
75. S.L. Swain et al., IL-4 directs the development of Th2-like helper effectors. J. Immunol., 1990, 145(11): 3796-806.
76. M.K. Racke et al., Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med., 1994, 180(5): 1961-6.
77. D. Abramowicz et al., Neonatal induction of transplantation tolerance in mice is associated with in vivo expression of IL-4 and -10 mRNAs. Transplant Proc., 1993, 25(1Pt 1): 312-3.
78. V. Donckier et al., IL-12 prevents neonatal induction of transplantation tolerance in mice. Eur. J. Immunol., 1998, 28(4): 1426-30.
79. Y. Bryson et al., Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol., 1980, 55: 191-200.
80. K. Katamura et al., Selective induction of interleukin-4- and interferon-y-producing T cells from cord blood naive T cells. Effects of costimulatory signaling through CD28. Int Arch. Allergy. Immunol., 1995, 106(2): 101-6.
81. D.J Reen, Activation and functional capacity of human neonatal CD4 T-cells. Vaccine. 1998, 16(14,15): 1401-8.
82. G. Delespesse et al., Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors. Vaccine, 1998, 16(14,15): 1415-9.
83. H.A Gans et al., IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants. J. Immunol., 1999, 162(9): 5569-75.
84. J.A. Byrne and M.B. Oldstone, Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol., 1984. 51(3): 682-6.
85. A.E. Lukacher, V.L. Braciale and T.J. Braciale, In vivo effector function of influenza virus-specific cytotoxic T Lymphocyte clones is highly specific. J. Exp. Med., 1984, 160(3): 814-26.
86. P.M. Huffman, E.F. Cimino and D.S. Robbins. Effects of viral specific cytotoxic lymphocytes on the expression of murine leukemia virus induced neurologic disease. J. Neuroimmunol., 1991, 33(2): 157-65.
87. Y. Riviere and F. Buseyne, Cytotoxic T lymphocytes generation capacity in early life with particular reference to HIV. Vaccine, 1998, 16(14,15): 1420-2.
88. T. Mizuochi et al., Role of lymphokine-secreting CD8 + T cells in cytotoxic T lymphocyte responses against vaccinia virus. J. Immunol., 1989, 142(1): 270-3.
89. W.R. Heath, L. Kjer-Nielsen and M.W. Hoffmann, Avidity for antigen can influence the helper dependence of CD8 + T lymphocytes. J. Immunol., 1993, 151(11): 5993-6001.
90. M. Sarzotti, M.D.P. Gomes and P.M. Hoffman, IFN-gamma production in response to neuropathogenic Cas-Br-M murine leukemia virus infection. Viral Immunol., 1993, 6(3): 207-17.
91. D.H. Schwartz and P.C. Doherty. Virus-immune and alloreactive response characteristics of thymocytes and spleen cells from young mice. J. Immunol., 1981, 127(4): 1411-4.
92. L. M. Pilarski, Ontogeny of cell-mediated immunity. I. Early development of alloantigen-specific cytotoxic T-cell precursors in postnatal mice. J. Exp. Med., 1977, 146(3): 887-92.
93. M.B. Oldstone et al., Vaccination to prevent persistent viral infection. J. Virol., 1993, 67(7): 4372-8.
94. D. Isaacs, C.R. Bangham and A.J. McMichael, Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet, 1987, 2(8562): 769-71.
95. I.N. Mbawuike et al., Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine. J. Med. Virol., 1996, 50(2): 105-11.
96. C. Brander et al., Persistent HIV-1-specific CTL clonai expansion despite high viral burden post in utero HIV-1 infection. J. Immunol., 1999, 162(8): 4796-800.
97. K McIntosh and S.K. Burchett, Clearance of HIV-lessons from newborns (editorial; comment). N. Engl. J. Med., 1995, 332(13): 883-4.
98. Y.J. Bryson et al., Clearance of HIV infection in a perinatally infected infant (see comments). N. Engl. J. Med., 1995, 332(13): 833-8.
99. S.A, Plotkin, Vaccines for varicella-zoster virus and cytomegalovirus: recent progress. Science, 1994, 265(5177): 1383-5.
100. S.L. Katz and B.G. Gellin. Measles vaccine: do we need new vaccines or new programs? Science, 1994, 265(5177): 1391-2.
101. C.B. Hall, Prospects for a respiratory syncytial virus vaccine. Science, 1994, 265(5177): 1393-4.
102. Y.W. Tang and B.S. Graham, Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J. Clin. Invest., 1994, 94(5): 1953-8.
103. T.W, Baba et al., Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science, 1995, 267(5205). 1820-5.
104. C. Barrios et al., Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects. Eur. J. Immunol., 1996, 26(11): 2666-70.
105. J.J. Donnelly et al., DNA vaccines. Annu Rev Immunol, 1997, 15: 617-48.
106. A. Bot et al., DNA immunization of newborn mice with a plasmid-expressing nucleoprotein of influenza virus. Viral Immunol., 1996, 9(4): 207-10.
107. M. Sarzotti et al., Induction of cytotoxic T cell responses in newborn mice by DNA immunization. Vaccine, 1997, 15(8): 795-7.
108. A.M. Prince, R. Whalen and B. Brotman, Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus. Vaccine, 1997, 15(8): 916-9.
109. Y. Wang et al., Immune response to neonatal genetic immunization. Virology, 1997, 228(2): 278-84.
110. A. Bot et al., Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene. Int. Immunol., 1997, 9(11): 1641-50.
111. X. Martinez et al., DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc, Natl. Acad. Sci. USA, 1997, 94(16): 8726-31.
112. D.E Hassett, J. Zhang and J.L. Whitton, Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J. Virol., 1997, 71(10): 7881-8.
113. C Butts et al., DNA immunization of infants: potential and limitations. Vaccine, 1998, 16(14,15): 1444-9.
114. C.A. Siegrist et al., Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells? Vaccine, 1998, 16(14,15): 1473-8.
115. G. Mor et al., Induction of neonatal tolerance by plasmid DNA vaccination of mice J. Clin. Invest., 1996, 98(12): 2700-5.
116. S. Kurikka et al., Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatrics, 1995, 95(6): 815-22.
117. T. Abo et al., Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life. J. Exp. Med., 1983, 157(1): 273-84.
118. P.V. Sivakumar et al., Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1 + Ly-49-cells: a possible mechanism of tolerance during NK cell development. J. Immunol., 1999, 162(12): 6976-80.
119. A. Kubota et al., Diversity of NK cell receptor repertoire in adult and neonatal mice. J. Immunol., 1999, 163(1): 212-216.
120. M.S. Krangel et al., A distinct wave of human T cell receptor gamma/delta lymphocytes in the early fetal thymus: evidence for controlled gene rearrangement and cytokine production. J. Exp. Med., 1990, 172(3): 847-59.
121. C.T. Morita et al., TCR usage and functional capabilities of human gamma delta T cells at birth. J. Immunol., 1994, 153(9): 3979-88.
122. C.M. Kersten et al., Escherichia coli and Pseudomonas aeruginosa induce expansion of V delta 2 cells in adult peripheral blood, but of V delta 1 cells in cord blood. J. Immunol., 1996, 157(4): 1613-9.
123. D.H. Raulet et al., Developmental regulation of T-cell receptor gene expression. Nature, 1985, 314(6006): 103-7.